Search results
Merck to start studying lower dose of HIV drug after FDA hold
Reuters via Yahoo News· 2 years agoThe FDA has reviewed and agreed with the plan to study lower-dose versions of the once-daily pill...
Merck cancer drug deal caps pharma investment influx into ‘ADC’ field
BioPharma Dive via Yahoo Finance· 7 months agoWith the alliance, Merck joins Pfizer, AstraZeneca and Gilead in staking major bets on the potential...
Merck (MRK) Resumes HIV Studies on Islatravir With Lower Dose
Zacks via Yahoo Finance· 2 years agoMerck MRK announced that it will evaluate a lower dose of its HIV candidate islatravir in a phase...
Is Merck Stock A Buy As It Looks To Carve Share In The Cardiovascular Market?
Investor's Business Daily· 1 year agoMerck stock is lingering in a consolidation after the company unveiled promising test results for...
Merck To Start New Islatravir HIV Trials With Lower Dose After FDA Hold
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) will initiate a new Phase 3 program with once-daily islatravir to treat...
Sanders threatens to subpoena J&J, Merck CEOs over drug prices
BioPharma Dive via Yahoo Finance· 4 months agoA Congressional committee may subpoena the CEOs of Johnson & Johnson and Merck & Co. to testify...
Gilead (GILD) & MRK's HIV Oral Combo Shows Efficacy in Phase II
Zacks via Yahoo Finance· 3 months agoGilead (GILD) and Merck's (MRK) phase II study data demonstrates the efficacy of their oral...
Merck (MRK) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 4 months agoImage source: The Motley Fool. Merck (NYSE: MRK) Q4 2023 Earnings Call Feb 01, 2024, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
My Biggest Worry About Gilead Sciences
Motley Fool· 2 years agoIn Q2, HIV drugs generated more than two-thirds of its total revenue. If you delve further into the details, you'll see that two drugs -- Biktarvy and,...
Senate panel grills pharmaceutical company execs over prescription drug prices
USA TODAY via Yahoo News· 4 months agoA Senate committee chaired by Sen. Bernie Sanders grilled the top executives of three major...
